4/12/2023Trailing AstraZeneca and Merck, Junshi Reports Phase 3 Ovarian Cancer ...

4/11/2023 Seizing On Asia's Opportune Market for Novel Vaccines (PharmExec/Simo...

4/11/2023A Brief Review of China Pharmaceutical Anti-Monopoly in the Year of 20...

4/10/2023FT: Astellas to Stay Put in China Despite Growing Geopolitical Tension

4/8/2023South Korean Biotech Companies Seek to Diversify from China as US Tens...

4/8/2023Recent Executive Moves

4/8/2023EU-China Relations – Trade, Investment, and Recent Developments (Chin...

4/5/2023China's Out-Licensing Boom Continued in February with Big Oncology Dru...

4/5/2023WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Conti...

4/5/2023Pharmaron Plans UK Gene Therapy Expansion

4/4/2023Pfizer, Meck Reportedly Slashed Prices of COVID-19 Pills in China

4/1/2023China Further Intensifies Healthcare Cost Containment and Price Contro...

3/31/2023Recent Executive Moves

3/30/2023AstraZeneca, KYM Biosciences Complete Licensing Deal for Anticancer Dr...

3/30/2023Apollomics Announces Closing of Business Combination and Listing on Na...

3/30/2023IQVIA: Chinese Retail Pharmacy Sales up 5.2% in MAT Q4/2022

3/30/2023Central Government Issues the Notice on Further Facilitating Medical E...

3/30/2023Rxilient and Junshi form JV to Develop and Commercialize Toripalimab i...

3/29/2023JPO Publicizes 8th VBP Tender Outcome, Which Cuts Average Price by 56%

3/29/2023Investing in China's Healthcare Sector (China Briefing)

3/27/2023BioNTech and Oncoc4 Sign Strategic Collaboration for Novel Checkpoint ...

3/27/2023Hepalink's OncoVent Enter License Deal with Orient EuroPharma for Oreg...

3/24/2023InvoX Pharma's F-star Announces 2nd Licence Deal with Takeda

3/24/2023Pfizer Signs MOU with HCRC Aimed at Improving Rural Health in China

3/24/2023New Report: Incidence of Moderate and Severe Ovarian Hyperstimulation ...

3/23/2023Roche, CR Pharma Tie Up to Improve Access of Flu Drug Xofluza in Chna

3/23/2023Chinese Government Issues the Opinions for Further Improving Healthcar...

3/21/2023Therapeutic Antibody Licensing Deals in China: A 2022 End-Of-Year Summ...

3/17/2023Upgrading Medtech Commercial Operations in China (McKinsey)

3/17/2023CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...

Page:50/356 Total number of articles:10662: [First][<<] [48] [49] [50] [51] [52] [>>] [End]